Senator DI NATALE (Victoria) (14:57): Mr President, I ask a supplementary question. A further drug, dabigatran, which is a blood-thinning agent which can be used as an alternative to existing treatments, was recommended for listing on the PBS 18 months ago. Rather than funding the drug on the PBS, as is normal practice, the government commissioned a review of all blood-thinning drugs. I understand that the review is with the Minister for Health and Ageing. Minister, when will the recommendations from this review be made public and when will the recommendations be implemented?